AI-generated summary
The authors reviewed hematopoietic stem cell transplantation trials and recent evidence on photobiomodulation for preventing oral mucositis. In the POMFITT study (n = 30), severe mucositis occurred in 0 of 15 treated patients versus 4 of 15 controls, though the authors note this sparse comparison is sensitive to the statistical test used. Benefits for hospitalization, physical function and quality of life were not significant at discharge.
- Participants
- 30
- Who or what was studied
- Patients undergoing hematopoietic stem cell transplantation
- Limits stated in the abstract
- The authors note the sparse POMFITT comparison is sensitive to the statistical test used, and several supportive-care endpoints rest on indirect or preliminary evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.